Skip to content
Malta's world news feed Local perspective with global outlook
CDE.NEWS The Dispatch
Coronavirus

Drug shortage fears as India limits exports

Coronavirus advisory hangs at the entrance of the Infectious Diseases (ID) Hospital in Kolkata, India, 04 March 2020. According to media reports, at least 15 Italian tourists traveling in India have tested positive for COVID-19. The novel coronavirus outbreak has so far claimed more than 3000 lives and infected over 90,000 people worldwide. EPA-EFE/PIYAL ADHIKARY

There are fears of global shortages of some common drugs after India limited the export of certain medicines due to the coronavirus.

The world’s biggest supplier of generic drugs has restricted exports of 26 ingredients and the medicines made from them.

The Indian government has urged calm over its announcement and said there were enough stocks to last for up to three months.

In 2018 Indian imports accounted for almost a quarter of US medicines and more than 30% of medicine ingredients, according to the US Food and Drug Administration (FDA).

The restricted drugs include Paracetamol, one of the world’s most widely-used pain relievers.

It comes as many drug ingredient makers in China remain shut or cut output.

India’s drug makers rely on China for almost 70% of the active ingredients in their medicines, and industry experts have warned that they are likely to face shortages if the epidemic continues.

“Even drugs that aren’t produced in China get their base ingredients from China. Globally there could be a shortage if China and India both get hit,” warned analyst Shaun Rein from the China Market Research Group.

The list of ingredients and medicines accounts for 10% of all Indian pharmaceutical exports and includes several antibiotics, such as tinidazole and erythromycin, the hormone progesterone and Vitamin B12.

Read more via BBC

Filed under CoronavirusIndia

More from Coronavirus

More →